Heiman Wertheim MD, PhD

Heiman Wertheim is a professor in clinical microbiology and heads the clinical microbiology department at Radboud University Medical Center and is chair of the Radboud Center of Infectious Diseases (RCI). Heiman is member of the ‘Raad voor Wetenschap en Innovatie’ at the Federatie Medisch Specialisten. Until 2015, Heiman was director of the Oxford University Clinical Research Unit (OUCRU) in Hanoi, Vietnam. One of his main interests is antibiotic resistance in both resource rich and resource constrained settings and does this through a multidisciplinary approach: health systems, policy development, behavior, surveillance, prevention, genomics, and clinical trials. Heiman was part of a WHO expert panel to develop a priority pathogens list (PPL) of antimicrobial resistant bacteria and currently he is on a panel to evaluate consequences of mass drug administration of azithromycin.